North America
Tags: Canada, Life SciencesBy Richard Y. Cheung, Ph.D., Toronto, Fasken Martineau DuMoulin
Due to concerns about the growing percentage of the health care budget allotted to drug spending in Canada and the relative drug prices in Canada compared to other developed countries, the Canadian government is proposing changes to the way in which prices for patented drugs are regulated …
Read or download the full article below.
Latest Updates
Related Articles
Related Articles by Jurisdiction
Canada: Intellectual Property Bulletin
The New Patented Medicines (Notice of Compliance) Regulations and Certificate of Supplementary Protection Regulations ...
Use of Trademarks As Metadata & #Hashtags in Canada
A recent decision of the Federal Court of Canada provides guidance on the proper use of IP in this digital world that brand owners need to know now.
Something old, something new: Canada's proposed Impact Assessment Act
The federal government recently proposed sweeping changes to Canada’s environmental legislation, including the environmental assessment process for major projects in Canada.
Latest Articles
